Chronic Kidney Disease-Epidemiology Formula and Model for End-Stage Liver Disease Score in the Assessment of Renal Function in Candidates for Liver Transplantation

被引:6
作者
Tinti, F. [1 ]
Lai, S. [1 ]
Umbro, I. [1 ]
Mordenti, M. [2 ]
Barile, M. [1 ]
Corradini, S. Ginanni [2 ]
Rossi, M. [3 ]
Poli, L. [3 ]
Nofroni, I. [4 ]
Berloco, P. B. [3 ]
Mitterhofer, A. P. [1 ]
机构
[1] Univ Roma La Sapienza, Fac Med & Chirurg 1, DAI Nefrourol, Rome, Italy
[2] Univ Roma La Sapienza, Fac Med & Chirurg 1, DAI Malattie Apparato Digerente & Endoscopia Dige, Rome, Italy
[3] Univ Roma La Sapienza, Fac Med & Chirurg 1, DAI Chirurg Gen Special Chirurg & Trapianti Organ, Rome, Italy
[4] Univ Roma La Sapienza, Fac Med & Chirurg 1, DAI Med Sperimentale & Patol, Rome, Italy
关键词
GLOMERULAR-FILTRATION-RATE; CREATININE CLEARANCE; SERUM CREATININE; CIRRHOSIS; FAILURE; ASCITES; PREDICTION; MORTALITY;
D O I
10.1016/j.transproceed.2010.03.129
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Assessment of renal function in patients with end-stage liver disease (ESLD) awaiting liver transplantation (OLT) is critical. Various conditions may cause renal damage in ESLD. Renal and liver functions are intertwined due to splanchnic hemodynamic relationships; renal failure rarely occurs in patients without advanced decompensated cirrhosis. The recent literature suggests that evaluation of renal function should include an assessment of liver function. The aim of this study was to evaluate different methods to estimate glomerular filtration rate (GFR) in patient among ESLD candidates for OLT over 1 year. We also correlated renal and hepatic functions. Fifty-two cirrhotic patients Model for End-Stage Liver Disease [MELD] > 10) were enrolled in the study. All patients were evaluated at baseline and every 4 months (T1-T4) thereafter for 1 year. The GFR was calculated by creatinine clearance, and estimated by Cockroft and Gault, Modified Diet Renal Disease (MDRD) 4 and 6 variable and Chronic Kidney Disease-Epidemiology (CKD-EPI) formulae. Hepatic functions were evaluated by MELD score, albumin, bilirubin, and International Normalized Ratio (INR). We observed not statistically significant increase mean value of MELD score, bilirubin, serum creatinine, and blood urea nitrogen and a reduced serum sodium. There were no significant differences among various methods to evaluate CFR at each time over 1 year. We did not observe any association between renal and hepatic function, except at T4 for MELD and GFR estimated with MDRD 4 (P = .009) and 6 (P = .008) parameters or CICD-EPI (P = .036), and MELD and sodium (P = .001). Our results showed that evaluation of renal function in cirrhosis should include an evaluation of hepatic function. In our case, MDRD and CKD-EPI seemed to be the more accurate formulae to evaluate renal function in relation to hepatic function.
引用
收藏
页码:1229 / 1232
页数:4
相关论文
共 28 条
[1]   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[2]   Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation [J].
Axelsen, RA ;
Crawford, DHG ;
Endre, ZH ;
Lynch, SV ;
Balderson, GA ;
Strong, RW ;
Fleming, SJ .
PATHOLOGY, 1995, 27 (03) :237-246
[3]   Renal failure after upper gastrointestinal bleeding in cirrhosis:: Incidence, clinical course, predictive factors, and short-term prognosis [J].
Cárdenas, A ;
Ginès, P ;
Uriz, J ;
Bessa, X ;
Salmerón, JM ;
Mas, A ;
Ortega, R ;
Calahorra, B ;
De las Heras, D ;
Bosch, J ;
Arroyo, V ;
Rodes, J .
HEPATOLOGY, 2001, 34 (04) :671-676
[4]   Review article: renal function assessment in cirrhosis - difficulties and alternative measurements [J].
Cholongitas, E. ;
Shusang, V. ;
Marelli, L. ;
Nair, D. ;
Thomas, M. ;
Patch, D. ;
Burns, A. ;
Sweny, P. ;
Burroughs, A. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (07) :969-978
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]   UNIVERSAL OCCURRENCE OF GLOMERULAR ABNORMALITIES IN PATIENTS RECEIVING LIVER-TRANSPLANTS [J].
CRAWFORD, DHG ;
ENDRE, ZH ;
AXELSEN, RA ;
LYNCH, SV ;
BALDERSON, GA ;
STRONG, RW ;
KERLIN, P ;
POWELL, LW ;
FLEMING, SJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (04) :339-344
[7]   Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I. [J].
Davis, CL ;
Gonwa, TA ;
Wilkinson, AH .
LIVER TRANSPLANTATION, 2002, 8 (02) :91-109
[8]   Identification of patients best suited for combined liver-kidney transplantation: Part II. [J].
Davis, CL ;
Gonwa, TA ;
Wilkinson, AH .
LIVER TRANSPLANTATION, 2002, 8 (03) :193-211
[9]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[10]   Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation [J].
Fraley, DS ;
Burr, R ;
Bernardini, J ;
Angus, D ;
Kramer, DJ ;
Johnson, JP .
KIDNEY INTERNATIONAL, 1998, 54 (02) :518-524